Stochastic modeling of drug resistance in cancer.
作者： Natalia Komarova
DOI: 10.1016/J.JTBI.2005.08.003
关键词: Oncology 、 Drug resistance 、 Treatment success 、 Pharmacology 、 Stochastic modelling 、 Turnover 、 Cancer 、 Internal medicine 、 Cancer cell 、 Treatment outcome 、 Drug
摘要: … We will model the dynamics as a stochastic process which is a sequence of transitions between different states. For each cell in a colony, we assume that there is a certain probability to …
elsevier.com
sci-hub.se 参考文章(42)
Goldie Jh, Coldman Aj, Quantitative model for multiple levels of drug resistance in clinical tumors. Cancer treatment reports. ,vol. 67, pp. 923- 931 ,(1983)
Jerry A. Howle, Glen R. Gale, Cis-dichlorodiammineplatinum (II). Persistent and selective inhibition of deoxyribonucleic acid synthesis in vivo. Biochemical Pharmacology. ,vol. 19, pp. 2757- 2762 ,(1970) , 10.1016/0006-2952(70)90102-4
James H. Goldie, Andrew James Coldman, Drug Resistance in Cancer: Mechanisms and Models ,(1998)
Goldie Jh, Coldman Aj, A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer treatment reports. ,vol. 63, pp. 1727- 1734 ,(1979)
Frank McCormick, New-age drug meets resistance Nature. ,vol. 412, pp. 281- 282 ,(2001) , 10.1038/35085665
G K Chen, G E Durán, A Mangili, L Beketic-Oreskovic, B I Sikic, MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells. British Journal of Cancer. ,vol. 83, pp. 892- 898 ,(2000) , 10.1054/BJOC.2000.1371
T. E. Wheldon, Mathematical models in cancer research A. Hilger. ,(1988)
Robert G McKinnell, None, The biological basis of cancer ,(1998)
Andrzej Świerniak, Jarosław Śmieja, Different Models of Chemotherapy Taking Into Account Drug Resistance Stemming from Gene Amplification International Journal of Applied Mathematics and Computer Science. ,vol. 13, pp. 297- 305 ,(2003)
Wayne S. Kendal, Philip Frost, Pitfalls and practice of Luria-Delbrück fluctuation analysis: a review. Cancer Research. ,vol. 48, pp. 1060- 1065 ,(1988)